Muscle Biology
1 – 10 of 72
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Potential therapies and biomarkers for LAMA2-CMD. Does the microRNA hype deliver?
- Effects of metformin on congenital muscular dystrophy type 1A disease progression in mice: a gender impact study
- Laminin α1 reduces muscular dystrophy in dy2Jmice
- 2017
- Bioenergetic Impairment in Congenital Muscular Dystrophy Type 1A and Leigh Syndrome Muscle Cells
- Potent pro-inflammatory and profibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chaindeficient muscular dystrophy
- Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD
- 2016
- Bortezomib Does Not Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy.
- Skeletal muscle wasting and renewal : a pivotal role of myokine IL-6
- Congenital muscular dystrophy with laminin α2 chain-deficiency. Initiation of disease and development of treatment
- Update on hereditary colorectal cancer